Clinical Trial: AI Algorithm-Informed Biopsy for Prostate Cancer Detection With Indeterminate and Low-Risk Prostate MRI Lesions

U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07231627) titled 'AI Algorithm-Informed Biopsy for Prostate Cancer Detection With Indeterminate and Low-Risk Prostate MRI Lesions' on Nov. 13.

Brief Summary: Use of AI algorithm for PCa detection is feasible, and AI-informed biopsies (AI-targeted and perilesional biopsy) improves csPCa detection in patients with indeterminate MRI lesions and in patients with low-risk MRI lesions and high-risk clinical features.

Study Start Date: Jan., 2026

Study Type: INTERVENTIONAL

Condition: Prostate Cancer

Intervention: DEVICE: Bi-parametric MRI-based cascaded deep-learning AI algorithm

Artificial intelligence system used in medical imaging, primarily for t...